Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco January DIC 600x60px
Document › Details

BASF Corporation. (3/22/17). "Press Release: BASF Licenses CRISPR-Cas9 Genome-editing Technology from the Broad Institute". Research Triangle Park, NC.

Region Region ALL
Organisations Organisation BASF Corporation
  Group BASF (Group)
  Organisation 2 Broad Institute (MIT / Harvard)
  Group MIT (Massachusetts Institute of Technology)
Products Product CRISPR gene editing technology
  Product 2 AGRI LIFE SCIENCES
Index term Index term BASF–MIT: CRISPR technology, 201703– license ww for agricultural + industrial microbiology applications from Broad Institute
Persons Person Eckes, Peter (BASF 201201 President of BASF Plant Science)
  Person 2 Rozen, Issi (MIT 201703 CBO at Broad Institute)
     


> Global licensing agreement to provide improved products in agricultural and industrial applications

> Genome editing seen as the next revolution in biotechnology


BASF today announced that it has reached a global licensing agreement with the Broad Institute of MIT and Harvard for the use of CRISPR-Cas9 genome-editing technology to improve products in agricultural and industrial microbiology applications.

The technology advances genome editing because it has the potential to be a simpler and more precise tool for making targeted changes to a cell's DNA. For BASF, it offers many benefits for advancing and delivering improved agricultural and industrial products faster and less expensively than other genome-editing methods.

'The CRISPR-Cas9 technology is a game changer within the field of genome editing,' said Peter Eckes, President of BASF Bioscience Research. 'We are eager to see the new ways it will augment our research and improve multiple products for agriculture as well as numerous industrial applications.'

'This technology represents a transformative application of genome editing for the research community,' said Issi Rozen, chief business officer of the Broad Institute. 'CRISPR-Cas9 can directly benefit advanced research across many industries including human health and agriculture. We are proud to partner with stakeholders throughout the biomedical and agriculture community to help deliver responsible solutions for our planet.'


About BASF

BASF Corporation, headquartered in Florham Park, New Jersey, is the North American affiliate of BASF SE, Ludwigshafen, Germany. BASF has more than 17,500 employees in North America, and had sales of $16.2 billion in 2016. For more information about BASF's North American operations, visit www.basf.us.

At BASF, we create chemistry for a sustainable future. We combine economic success with environmental protection and social responsibility. The approximately 114,000 employees in the BASF Group work on contributing to the success of our customers in nearly all sectors and almost every country in the world. Our portfolio is organized into five segments: Chemicals, Performance Products, Functional Materials & Solutions, Agricultural Solutions and Oil & Gas. BASF generated sales of about €58 billion in 2016. BASF shares are traded on the stock exchanges in Frankfurt (BAS), London (BFA) and Zurich (BAS). Further information at www.basf.com.

   
Record changed: 2017-04-19

Advertisement

Picture [iito] – Putting Information into Context 600x60px

More documents for BASF (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Investors 600x60px




» top